CA2836827C - Conjugues d'ester amine alpha hydrolysables par des coarboxylesterases - Google Patents
Conjugues d'ester amine alpha hydrolysables par des coarboxylesterases Download PDFInfo
- Publication number
- CA2836827C CA2836827C CA2836827A CA2836827A CA2836827C CA 2836827 C CA2836827 C CA 2836827C CA 2836827 A CA2836827 A CA 2836827A CA 2836827 A CA2836827 A CA 2836827A CA 2836827 C CA2836827 C CA 2836827C
- Authority
- CA
- Canada
- Prior art keywords
- amino acid
- inhibitor
- ester
- conjugate
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
La conjugaison covalente dun ester aminé alpha à un modulateur de l'activité dune enzyme intracellulaire cible ou dun récepteur, où le groupe ester du conjugué est hydrolysable par une ou plusieurs enzymes carboxylestérases intracellulaires à lacide correspondant, mène à laccumulation du produit dhydrolyse d'acide carboxylique dans la cellule et permet une modulation améliorée ou prolongée de lenzyme ou du récepteur par rapport au modulateur non conjugué.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0509226A GB0509226D0 (en) | 2005-05-05 | 2005-05-05 | Enzyme and receptor modulation |
| GB0509226.7 | 2005-05-05 | ||
| US68054205P | 2005-05-13 | 2005-05-13 | |
| US60/680,542 | 2005-05-13 | ||
| CA2607020A CA2607020C (fr) | 2005-05-05 | 2006-05-04 | Conjugues d'ester amine alpha hydrolysables par des coarboxylesterases |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2607020A Division CA2607020C (fr) | 2005-05-05 | 2006-05-04 | Conjugues d'ester amine alpha hydrolysables par des coarboxylesterases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2836827A1 CA2836827A1 (fr) | 2006-11-09 |
| CA2836827C true CA2836827C (fr) | 2016-05-03 |
Family
ID=34685158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2836827A Expired - Lifetime CA2836827C (fr) | 2005-05-05 | 2006-05-04 | Conjugues d'ester amine alpha hydrolysables par des coarboxylesterases |
Country Status (10)
| Country | Link |
|---|---|
| CN (1) | CN101171039B (fr) |
| CA (1) | CA2836827C (fr) |
| DK (1) | DK1877098T3 (fr) |
| ES (2) | ES2577433T3 (fr) |
| GB (1) | GB0509226D0 (fr) |
| NZ (1) | NZ561710A (fr) |
| PT (1) | PT1877098E (fr) |
| SG (1) | SG2014007512A (fr) |
| SI (1) | SI1877098T1 (fr) |
| ZA (1) | ZA200708283B (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02002505A (es) * | 1999-09-08 | 2004-09-10 | Sloan Kettering Inst Cancer | Nueva clase de agentes de citodiferenciacion e inhibidores de histona desacetilasa y metodos de utilizacion de los mismos. |
| EP1677785A1 (fr) * | 2003-10-22 | 2006-07-12 | Arpida A/S | Derives de benzimidazole et leur application comme inhibiteurs de la peptide-deformylase |
-
2005
- 2005-05-05 GB GB0509226A patent/GB0509226D0/en not_active Ceased
-
2006
- 2006-05-04 ES ES08075300.7T patent/ES2577433T3/es not_active Expired - Lifetime
- 2006-05-04 CA CA2836827A patent/CA2836827C/fr not_active Expired - Lifetime
- 2006-05-04 ES ES06727008T patent/ES2415244T3/es not_active Expired - Lifetime
- 2006-05-04 SG SG2014007512A patent/SG2014007512A/en unknown
- 2006-05-04 DK DK06727008.2T patent/DK1877098T3/da active
- 2006-05-04 PT PT06727008T patent/PT1877098E/pt unknown
- 2006-05-04 SI SI200631620T patent/SI1877098T1/sl unknown
- 2006-05-04 NZ NZ561710A patent/NZ561710A/en not_active IP Right Cessation
- 2006-05-04 CN CN200680014981.9A patent/CN101171039B/zh not_active Expired - Fee Related
-
2007
- 2007-09-27 ZA ZA200708283A patent/ZA200708283B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2577433T3 (es) | 2016-07-14 |
| DK1877098T3 (da) | 2013-07-08 |
| CN101171039B (zh) | 2013-01-23 |
| GB0509226D0 (en) | 2005-06-15 |
| SG2014007512A (en) | 2014-03-28 |
| SI1877098T1 (sl) | 2013-08-30 |
| NZ561710A (en) | 2010-08-27 |
| CN101171039A (zh) | 2008-04-30 |
| CA2836827A1 (fr) | 2006-11-09 |
| PT1877098E (pt) | 2013-07-31 |
| ES2415244T3 (es) | 2013-07-24 |
| ZA200708283B (en) | 2008-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2607020C (fr) | Conjugues d'ester amine alpha hydrolysables par des coarboxylesterases | |
| Tenora et al. | Tumor-targeted delivery of 6-diazo-5-oxo-l-norleucine (DON) using substituted acetylated lysine prodrugs | |
| US9636409B2 (en) | Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters | |
| CN101820848B (zh) | 抑制n-酰基乙醇胺水解性酸酰胺酶的组合物和方法 | |
| EP2949344A2 (fr) | Utilisation d'enzymes intracellulaires pour libérer des produits bioactifs liés par covalence | |
| McDonnell et al. | Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling | |
| CN103974934B (zh) | 使用sirt2调节剂的治疗方法 | |
| CA2836827A1 (fr) | Conjugues d'ester amine alpha hydrolysables par des coarboxylesterases | |
| US20240360089A1 (en) | Metabolically Stable HDAC Inhibitors with Trifluoromethylpyruvamide as Metal-Binding Group | |
| Span et al. | Deciphering the therapeutic potential of novel pentyloxyamide-based class I, IIb HDAC inhibitors against therapy-resistant leukemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20131217 |
|
| H11 | Ip right ceased following rejected request for revival |
Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED Effective date: 20241106 |